Navigation Links
Study questions assumptions about human sensitivity to biological motion
Date:10/17/2007

Rockville, MD -- Humans may not be any more sensitive in detecting biological motion compared with nonbiological motion, concludes a study recently published in Journal of Vision, an online, free-access publication of the Association for Research in Vision and Ophthalmology (ARVO).

Dr Eric Hiris of St. Mary's College of Maryland, (St Mary's City, MD, US) contends that although many papers on the subject begin with statements to the effect that humans are particularly sensitive in detecting point-light biological motion, little research has been performed that supports this.

Previous research in this area, according to Hiris, generally has failed to take into account form information in biological motion and/or has used masks that were less than optimal for biological motion.

Using point-light displays, Hiris's study, described in "Detection of biological and nonbiological motion," (http://www.journalofvision.org/7/12/4/) compared biological motion to nonbiological motion with and without an underlying form; equated the effectiveness of masks across displays; and presented targets of various sizes within a constant-sized mask area to determine if mask density predicted detection performance.

Hiris concludes that the resulting evidence does not show that humans are better able to detect biological motion if nonbiological motion contains an underlying form, and, in some cases, even if it does not.

"Do researchers sometimes state conclusions in ways that go beyond the data?" asks Hiris. "Specifically, what do researchers mean when they say we're 'highly sensitive' to some aspect of motion? These findings may highlight the need to be careful about how we couch our conclusions."


'/>"/>

Contact: Joanne Olson
jolson@arvo.org
240-221-2923
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Page: 1

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: